Vanguard Capital Management’s Mesa Laboratories MLAB Stock Holding History
Bought
Maintained
Sold
Other funds holding MLAB
Vanguard Capital Management's MLAB Position: Q3 2026 in Review
Vanguard Capital Management reduced its Mesa Laboratories (MLAB) stake by 0.52% in Q3 2026, selling an estimated $141K and leaving 236,214 shares worth $30.7M. The position accounts for ﹤0.01% of the portfolio, ranked #2166.
Vanguard Capital Management first reported a position in MLAB in Q1 2026 and has held it in 3 quarters since. 184 funds tracked by Wall St. Rank hold MLAB as of Q3 2026.
- Vanguard Capital Management held 236,214 shares of Mesa Laboratories worth $30.7M as of Q3 2026.
- Vanguard Capital Management sold 1,243 Mesa Laboratories shares in Q3 2026, an estimated $141K.
- Mesa Laboratories made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #2166 holding.
- Vanguard Capital Management first reported a position in Mesa Laboratories in Q1 2026 and has held it in 3 quarters since.
- 184 funds tracked by Wall St. Rank held Mesa Laboratories as of Q3 2026.
Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.